FDA Approves New AndroGel Formulation

Share this article:

The FDA has approved Abbott's AndroGel 1.62%, a testosterone gel that restores levels of the hormone in hypogonadal men with half the volume of gel at the starting dose than delivered in AndroGel 1%.

The newly approved formulation contains 40.5 mg of testosterone in two pump presses, compared with the 1% gel's 50 mg in four pump presses.

With different dosage and administration instructions, the two gels are not interchangeable.

Share this article:
You must be a registered member of RUN to post a comment.

More in Hypogonadism

Common Chemicals Lower Testosterone

Common Chemicals Lower Testosterone

Chemicals found in many household products may reduce androgen levels in both sexes.

Testosterone Supplements Not Linked to Heart Attacks

Testosterone Supplements Not Linked to Heart Attacks

Finding runs counter to some prior reports; much larger trials are needed, experts say.

Topical Testosterone Gel Approved

Topical Testosterone Gel Approved

In a study, 74% of men treated with Vogelxo achieved normal testosterone levels within 90 days.